Advertisement · 728 × 90
#
Hashtag
#nephcards2018
Advertisement · 728 × 90
Post image

Our nursing staff at the cme event #nephcards2018

0 0 0 0
Post image

@drnupur_21 on NOACS and ckd #nephcards2018

0 0 0 0
Post image

@danielwross4 using polls to teach lvad and kidney #nephcards2018

0 0 0 0
Post image

David Majure on #lvad #nephcards2018

0 0 0 0
Post image

Special thanks to @jradnephro on cardiorenal syndrome #nephcards2018

0 0 0 0
Post image

Amazing talk on contrast nephropathy @PaulPalevsky #nephcards2018

0 0 0 0
Post image

Planning committee #nephcards2018

0 0 0 0

Chf management in ckd. #nephcards2018 www.ajkd.org/article/S0272-6386(18)30... @AJKDonline

0 0 0 0

@Renal_MD Thanks for your amazing end of talk summaries for #nephcards2018

0 0 0 0
Post image

#nephcards2018 #lvad #tavr @danielwross4

0 0 0 0

Special thanks @SLeonMD @KhurramKidney for live tweets for the conference #nephcards2018

0 0 0 0
Post image Post image Post image

#nephcards2018

0 0 0 0
Post image

#nephcards2018 Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review.

0 0 0 0
Post image

#nephcards2018 Acute Kidney Injury Associated with Cardiac Surgery

0 0 0 0
Post image

#nephcards2018

0 0 0 0

#nephcards2018 THE EVOLVING ROLE OF BIOMARKERS IN CARDIAC SURGERY ASSOCIATED AKI

0 0 0 0
Post image

#nephcards2018

0 0 0 0
Post image

#nephcards2018 Very important topic!

0 0 0 0
Post image

#nephcards2018

0 0 0 0
Post image

#nephcards2018

0 0 0 0
Post image

#nephcards2018 Risk stratification and testing algorithm

0 0 0 0

#nephcards2018 ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease:

0 0 0 0

#nephcards2018 Cardiac Disease Evaluation and Management Among
Kidney and Liver Transplantation Candidates

0 0 0 0
Post image Post image

#nephcards2018 Diabetes, CKD and Cardiovascular disease connection...

0 0 0 0

#nephcards2018 In a meta-analysis which included 28 studies (3931 patients), an elevated troponin T (> 0.1 ng/mL) identifies a subgroup of ESRD patients who have poor survival and a high risk of cardiac death despite being asymptomatic.

0 0 0 0
Post image

#nephcards2018 The renal patient with coronary artery disease: Current concepts and dilemmas

0 0 0 0
Post image

#nephcards2018 Cardiovascular Morbidity and Mortality in CKD Patients

0 0 0 0
Post image

#nephcards2018

0 0 0 0
Post image

#nephcards2018
Conclusion: anticoagulation of patients with severe CKD and ESRD remains a topic of debate. CKD increases the risk of both thromboembolism and hemorrhage. Decision to anticoagulate and choice of agent should be individualized.

0 0 0 0
Post image Post image

#nephcards2018

0 0 0 0